Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Accenture
Covington
McKesson
Johnson and Johnson
QuintilesIMS
Deloitte
McKinsey
Dow
Novartis

Generated: January 17, 2018

DrugPatentWatch Database Preview

OVRAL Drug Profile

« Back to Dashboard

Which patents cover Ovral, and what generic alternatives are available?

Ovral is a drug marketed by Wyeth Pharms and is included in two NDAs.

The generic ingredient in OVRAL is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.

US Patents and Regulatory Information for OVRAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms OVRAL ethinyl estradiol; norgestrel TABLET;ORAL-21 016672-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms OVRAL-28 ethinyl estradiol; norgestrel TABLET;ORAL-28 016806-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for OVRAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms OVRAL ethinyl estradiol; norgestrel TABLET;ORAL-21 016672-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Wyeth Pharms OVRAL ethinyl estradiol; norgestrel TABLET;ORAL-21 016672-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Wyeth Pharms OVRAL ethinyl estradiol; norgestrel TABLET;ORAL-21 016672-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Novartis
Johnson and Johnson
Medtronic
Cerilliant
UBS
Teva
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot